Stock Track | Quidel (QDEL) Surges 8.70% Pre-Market as UBS Raises Target Price to $31

Stock Track11-06

Shares of Quidel Corporation (QDEL) soared 8.70% in pre-market trading on Thursday, following a significant target price upgrade from UBS. The Swiss investment bank raised its price target for QuidelOrtho from $26 to $31, signaling increased confidence in the company's future performance.

The substantial target price increase of 19.2% from UBS has sparked investor interest in the healthcare diagnostics company. This positive outlook from a major financial institution suggests that QuidelOrtho's business prospects and growth potential may be stronger than previously anticipated.

Additionally, analysts have been showing mixed opinions on various healthcare stocks, including QuidelOrtho, as reported in recent market analyses. This heightened attention from the financial community could be contributing to the increased trading activity and positive sentiment surrounding QDEL stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment